LiquidScan for Fetal Cell Analysis

About BioFluidica

BioFluidica is a pioneering liquid biopsy company with a versatile, automated platform that consolidates the isolation of multiple biomarker classes (cells, exosomes, cfDNA). Founded in 2007, the company has clinically validated its system across nine different cancer and prenatal sample types and operates both a product sales and a fee-for-service business model. While its instruments and services are currently for research use, the platform's demonstrated flexibility and ultralow sensitivity position it as a potential future tool for clinical diagnostics in precision medicine.

Therapeutic Areas